IGEA Medical

IGEA is a leading biomedical company specializing in the clinical application of bioelectric fields for oncology and orthopedics. The company is a pioneer in electroporation technology, specifically through its Cliniporator platform, which enables Electrochemotherapy (ECT) for the treatment of cutaneous and visceral tumors. By applying controlled electric pulses, IGEA's technology temporarily increases cell membrane permeability, significantly enhancing the local uptake of chemotherapy agents. Beyond oncology, the company provides biophysical stimulation therapies designed to promote bone healing and cartilage protection in orthopedic patients. Headquartered in Italy, IGEA maintains a strong international presence through clinical research and collaborations with major European cancer centers.